#CSHAsia
LightNews LightNews
cshasia.bsky.social
#CSHAsia # Genome Editing: All Things Considered
📍Suzhou, China | November 9-13, 2026
👉Register: www.csh-asia.org?content/3220
September 17, 2026 at 5:27 AM
cshasia.bsky.social
Our Invited Speaker List Has Been Updated! ⭐
#CSHAsia Meeting | Advances in Optical Interrogation of Living Cells and Organisms: Focus on the Brain
Suzhou, China | May 10–14, 2027
www.csh-asia.org?content/3278
September 15, 2026 at 3:02 AM
cshasia.bsky.social
📢 Abstract Deadline Extended!
The abstract submission deadline has been extended to October 2, 2026 for the [#CSHAsia] Meeting “RNA Biology.”
📍 Suzhou, China
📅 November 16-20, 2026

🗓️ New deadline: October 2, 2026
September 15, 2026 at 3:01 AM
cshasia.bsky.social
#CSHAsia Meeting on Cell Death & Metabolism will be held November 15-19, 2027, in Suzhou, China.
Register now at the Early Bird rate before October 18, 2027!
www.csh-asia.org?content/3186
September 14, 2026 at 3:15 AM
jem.org
The transcription factor IRF8 drives tumor-specific exhaustion in CD8⁺ T Cells. From Marco Ongaro, Grégory Verdeil and colleagues: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 11, 2026 at 12:01 AM
cshasia.bsky.social
#CSHAsia Meeting on Microbiome and Barrier Immunity will be held October 25-29, 2027, in Suzhou, China.
Register now at the Early Bird rate before September 27, 2027!
www.csh-asia.org?content/3254
#Microbiome #Barrier Immunity #Infection #tumor
September 10, 2026 at 2:47 AM
cshasia.bsky.social
#CSHAsia Meeting | Genomics of Rare Diseases
📍 Suzhou, China
📅 September 20–24, 2027
Join leading researchers from around the world to explore the latest advances.
📣 Abstract submission is now open!
Submit your abstract by July 16, 2027, and share your research with the scientific community.
September 10, 2026 at 2:42 AM
jem.org
Intravesical mesothelin-based #CARTcells targeting MUC16 effectively control #BladderCancer in preclinical models. From Parwiz Abrahimi, Renier Brentjens, Jedd Wolchok, Taha Merghoub et al.: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 10, 2026 at 12:01 AM
drjonlim.bsky.social
Great to be here in Suzhou 🇨🇳 this week for #CSHAsia Cancer Immunotherapy meeting. Looking forward to learning from colleagues and discussing science 👇
cshasia.bsky.social Cold Spring Harbor Asia meetings & courses @cshasia.bsky.social · Aug 21
#CSHAsia #CancerImmunotherapy #Immunology #CancerResearch
Join us this September for the CSHA Symposium on Cancer Immunotherapy!

👉 Submit your registration: www.csh-asia.org?content/2986
September 9, 2026 at 7:07 AM
jem.org
CD1d remodels the tumor-infiltrating myeloid populations controlling anti-tumor immunity. From Lauren Evans, Maria Conde Poole, Patricia Barral @barrallab.bsky.social: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 9, 2026 at 12:01 AM
jem.org
@ostendorflab.org, @immushuang.bsky.social, @sohailtavazoie.bsky.social et al. show that activation of LXRs elicits a T cell "pre-effector" state that enhances priming and promotes anti-tumor immunity. rupress.org/jem/article/...

In #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 9, 2026 at 3:00 AM
cshasia.bsky.social
Call for Abstracts! #CSHAsia # RNA Biology
📍Suzhou, China | Nov. 16-20, 2026
⌛️Abstract deadline due by Sept. 11, 2026
Early bird rate is available by Oct.16, 2026
👉checking more detailed information via www.csh-asia.org?content/3107
September 9, 2026 at 2:41 AM
cshasia.bsky.social
Updated Invited Speaker List!
#CSHAsia symposium on Novel Insights into Glia Function & Dysfunction, Suzhou, Nov. 30 - Dec. 4, 2026.
Register now for the early price before Oct. 30, 2026
www.csh-asia.org?content/2938
#glia #Microglia #Astrocyte #Oligodendrocyte, NG2 #CNS disorders
September 9, 2026 at 3:02 AM
cshasia.bsky.social
#CSHAsia Meeting | Advances in Optical Interrogation of Living Cells and Organisms: Focus on the Brain
Suzhou, China | May 10–14, 2027

Join leading researchers to explore the latest advances in optical interrogation before March 5, 2027.
www.csh-asia.org?content/3278
September 9, 2026 at 2:57 AM
jem.org
Targeting Mettl8-Tcf1 axis promotes CD8⁺ TPEX differentiation and antitumor immunity. From Jiaxi Song, Dan Cui, Qizhao Huang, Jia Li, Fengyin Li, and colleagues: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 8, 2026 at 3:00 AM
jem.org
Tumor-reactive LAG3⁺CD8⁺ T cells diverge into terminally exhausted cells and long-lived memory T cells. From Vaishali Aggarwal, Yangxi Sun, Chang Liu, Dario Vignali @vignalilab.bsky.social: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 8, 2026 at 12:00 AM
jem.org
PRECISE-seq reveals disease-relevant TCR repertoires with phenotypic plasticity. From Shibo Liu, Guanghao Liang, Yayun Yang, Yanyang Shi, Lihui Dong, Peng R. Chen, Meng Michelle Xu et al.: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 7, 2026 at 3:00 AM
jem.org
In this review, Almonte, Thomas, and Zitvogel highlight how the gut #microbiome modulates immune checkpoint blockade efficacy in #cancer. rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 7, 2026 at 12:00 AM
jem.org
T cell engagers emerge as a compelling therapeutic modality. A review from Baeuerle, Grieshaber-Bouyer, Sauer, and Michaelson: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 6, 2026 at 12:01 AM
jem.org
Advances in the development of personalized neoantigen therapies. Mirabile–Brightman and Butterfield discuss the status of cancer vaccination in this review: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 5, 2026 at 12:00 AM
jem.org
Ward, Kar, Balan & @bhardwajlab.bsky.social review how conventional cDC1s coordinate antitumor immunity through cross-presentation, immune cell networking, and spatial organization in tumors. rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 3, 2026 at 3:15 PM
cshasia.bsky.social
#CSHAsia Meeting on Molecular Mechanisms and Physiology of Unconventional Protein Secretion will be held April 19–23, 2027, in Suzhou, China.
Register now at the Early Bird rate before March 22, 2027!
www.csh-asia.org?content/3231
#unconventional protein secretion #ER, Golgi, and endosomes
August 28, 2026 at 3:20 AM
cshasia.bsky.social
#CSHAsia Meeting | Advances in Optical Interrogation of Living Cells and Organisms: Focus on the Brain
Suzhou, China | May 10–14, 2027
Submit your abstract before March 5, 2027.
www.csh-asia.org?content/3278
August 28, 2026 at 3:29 AM
cshasia.bsky.social
#CSHAsia symposium on Novel Insights into Glia Function & Dysfunction | Suzhou China, Nov. 30 - Dec. 4, 2026.
Abstract deadline: Sept. 25, 2026.
webpage: www.csh-asia.org?content/2938
Early price before Oct. 30, 2026
#glia #Microglia #Astrocyte #Oligodendrocyte, NG2 #Neurological Disease
August 26, 2026 at 3:09 AM
cshasia.bsky.social
Call for Abstracts! #CSHAsia # RNA Biology
📍Suzhou, China | Nov. 16-20, 2026
⌛️Abstract deadline due by Sept. 11, 2026
Early bird rate is available by Oct.16, 2026
👉checking more detailed information via www.csh-asia.org?content/3107
August 26, 2026 at 3:01 AM